We are monitoring the impact of COVID-19 & Recession alarm on North America Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

North America Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End-User and Country (the United States, Canada and Rest of North America) – Industry Size, Share, Trends and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1126
Pages: 134

North America Autoimmune Diagnostics Market Size (2022 to 2027)

The size of the Autoimmune Diagnostics Market size in North America was worth USD 6.08 billion in 2022. It is estimated to reach USD 7.19 billion by the end of 2027, with a growing potential of 3.40%.

NIH expected that up to 23.5 million Americans have an Autoimmune disorder. In comparison, heart diseases up to 22 million and cancer affects up to 9 million people in America. So, NIH estimates that the annual direct health spending on autoimmune diagnostics is nearly 100 billion (USD). With 50 million Americans living and coping with autoimmune disorders, more than 75% of them are women. Autoimmune diseases affect women three times more than men. Some of these diseases have an even higher incidence in women. Autoimmune diseases have been mentioned in the top ten leading causes of the deaths among U.S. women aged 65 and younger. So, these diseases represent the fourth-largest cause of disability among women in the United States.

The North American Autoimmune Disease Diagnostics market is primarily driven by a few key factors such as the increasing prevalence of autoimmune diseases, patient awareness of growing health issues, increasing healthcare spending, increasing initiatives government, and the rise of automation technologies leading to greater sensitivity, faster and more comfortable performance of disease prevention and diagnostic test results. North America occupies a leading position in the autoimmune disease diagnostics market due to the increasing incidence of autoimmune diseases such as rheumatoid arthritis, type I diabetes, increasing infrastructure health care, and increasing per capita income, and strengthening multinationals in their distribution network followed by Europe. The major driving factors that have driven the growth of the Autoimmune Disease Diagnostics market in this region are the ever-increasing regulatory scenario being watched by various organizations such as World Health Organization (WHO) for safety issues and health, technological progress in the search for new techniques, increased funding in public and private sectors

Supportive government policies, and increasing public awareness, increasing the occurrence of Autoimmune disorders, advancements in health care, and improved laboratory techniques are the factors driving the growth of the market.

However, the autoimmune disease diagnostics market is faced with several challenges, such as a high frequency of false-positive results and long turnaround time for diagnostic test results. Diagnosis of autoimmune diseases Market testing is expensive, which is a significant limitation for the market. The autoimmune disease diagnostics market faces enormous challenges due to inadequate knowledge of various conditions and diagnostic measures. Low-income companies and growing economies are presenting themselves to solve these problems for the autoimmune disease diagnostics market. The lack of healthcare professionals with the skills to manage and treat autoimmune diseases will hamper the industry's growth for years to come.

This report on the North America Autoimmune Diagnostics Market has been segmented & sub-segmented into the following categories:

  • By Test Type: Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C-reactive protein (CRP), Comprehensive Metabolic Panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR), and Others
  • By Disease Type: Localized Autoimmune Disease Diagnostics (Graves' Disease, Hashimoto's Thyroiditis, Multiple Sclerosis, Type 1 Diabetes, Psoriasis, And Others), Systemic Autoimmune Disease Diagnostics (Rheumatoid Arthritis (RA), Ankylosing Spondylitis and Systemic Lupus Erythematosus (SLE))
  • By End User: Hospitals, Research Centers and Diagnostic Laboratories
  • By Country: the United States, Canada, and Rest of North America

Geographically, In North America, the U.S. and Canada have emerged as the most lucrative markets for autoimmune disease diagnostics. So, both these countries boast sophisticated healthcare infrastructure with advanced laboratory techniques and increasing awareness about various medical procedures. The overall high healthcare expenditure across the region puts North America at the front in the global autoimmune disease diagnostics market

The North American autoimmune disease diagnostics market has been dominated by the US autoimmune disease diagnostics market and is expected to show a positive trend throughout the projection period. The Canadian autoimmune disease diagnostics industry is expected to keep pace with the US autoimmune disease diagnostics market progress at a CAGR of 2.0% during the forecast period. The increasing prevalence of autoimmune diseases in Canada is driving market growth. According to the recently published article, approximately 5.2 million Canadians are affected by autoimmune diseases. Canada devoted about 11.7% of its total GDP to the health sector in 2020. Health care spending in Canada is continually increasing, and the trend is expected to continue for the forecast period. Besides, the growing research and development activities in the country will significantly impact the growth of the autoimmune diagnostics industry in Canada.

Some of the major companies dominating the North America Autoimmune disease market by their products and services include Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly, GlaxoSmithKline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

 

  1. North America Autoimmune Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  2. North America Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  3. North America Autoantibody Tests Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Antinuclear Antibody Tests Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Complete Blood Count (CBC) Market, By Region, From 2022 - 2027 (USD Billion)
  6. North America C - reactive protein (CRP) Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America Comprehensive Metabolic panel Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Urinalysis Market, By Region, From 2022 - 2027 (USD Billion)
  9. North America Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2022 - 2027 (USD Billion)
  10. North America Other Test Types Market, By Region, From 2022 - 2027 (USD Billion)
  11. North America Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  12. North America Localized Autoimmune Diseases Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  13. North America Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  14. United States Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  15. United States Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  16. Canada Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  17. Canada Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  18. North America Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  19. North America Graves' Disease Market, By Region, From 2022 - 2027 (USD Billion)
  20. North America Hashimoto's Thyroiditis Market, By Region, From 2022 - 2027 (USD Billion)
  21. North America Multiple Sclerosis Market, By Region, From 2022 - 2027 (USD Billion)
  22. North America Type 1 diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  23. North America Psoriasis Market, By Region, From 2022 - 2027 (USD Billion)
  24. North America Other Localized Autoimmune Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  25. United States Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  26. Canada Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  27. North America Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  28. North America Rheumatoid Arthritis (RA) Market, By Region, From 2022 - 2027 (USD Billion)
  29. North America Ankylosing Spondylitis Market, By Region, From 2022 - 2027 (USD Billion)
  30. North America Systemic Lupus Erythematosus (SLE) Market, By Region, From 2022 - 2027 (USD Billion)
  31. United States Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  32. Canada Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample